Trazodone vs. Quviviq
See how Trazodone and Quviviq compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Trazodone is FDA-approved only for major depressive disorder, so using it for insomnia is an off-label practice not reviewed by the FDA for that purpose.
Quviviq (daridorexant) is a dual orexin receptor antagonist specifically FDA-approved for insomnia in adults, with its own controlled-substance and hepatic dosing rules.
Generic trazodone costs far less per month than Quviviq, but Quviviq's label includes clinical trial data on sleep onset and maintenance that trazodone's label does not.
Trazodone vs. Quviviq Drug Summary
Trazodone
Trazodone is a serotonin antagonist and reuptake inhibitor (SARI) antidepressant that the FDA approved for major depressive disorder in adults. It is not FDA-approved for insomnia, but it is widely prescribed off-label at lower bedtime doses to help people fall and stay asleep. For depression it is taken multiple times a day in divided doses; for sleep it is typically taken once at night.
Quviviq
Quviviq (daridorexant) is a dual orexin receptor antagonist, a newer class of sleep medication that blocks wake-promoting orexin signals in the brain. It is FDA-approved specifically for adults with insomnia who have trouble falling asleep, staying asleep, or both. It comes as a tablet taken once nightly, close to bedtime, at either 25 mg or 50 mg.
Trazodone vs. Quviviq Side Effects
Trazodone
Quviviq
Trazodone vs. Quviviq Dosage
Trazodone
Quviviq
| STAGE | DOSE | WHEN |
| Starting dose | 25-50 mg at bedtime | At the start |
| Maximum dose | Up to 150 mg nightly | If needed |
| Dose changes | 2 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 25 mg once nightly | At the start |
| Maximum dose | 50 mg once nightly | If needed |
| Dose changes | 1 increase | As tolerated |
Trazodone
| STAGE | DOSE | WHEN |
| Starting dose | 25-50 mg at bedtime | At the start |
| Maximum dose | Up to 150 mg nightly | If needed |
| Dose changes | 2 increases | As tolerated |
Quviviq
| STAGE | DOSE | WHEN |
| Starting dose | 25 mg once nightly | At the start |
| Maximum dose | 50 mg once nightly | If needed |
| Dose changes | 1 increase | As tolerated |
Trazodone vs. Quviviq Indications
Trazodone
Trazodone's only FDA-approved use is major depressive disorder in adults, with treatment starting at 150 mg per day in divided doses. Despite this, it is one of the most commonly prescribed medications for insomnia, used off-label at much lower bedtime doses. This off-label use is common in practice, but it has not been formally reviewed by the FDA for sleep specifically.
Major depressive disorder (FDA-approved)
Insomnia (off-label use only)
Sleep disturbance linked to depression or anxiety (off-label)
Sometimes used off-label as a non-habit-forming option for people with substance use history
Quviviq
Quviviq is FDA-approved for adults with insomnia, specifically for difficulty falling asleep, staying asleep, or both. It is not approved for narcolepsy or for use in children. As a Schedule IV controlled substance, it carries its own prescribing and monitoring requirements.
Difficulty falling asleep (FDA-approved)
Difficulty staying asleep (FDA-approved)
Adults only; not studied for pediatric insomnia
Not approved for narcolepsy
Trazodone vs. Quviviq Pros and Cons
Trazodone
Trazodone is a decades-old generic antidepressant with a long track record and low cost, but its use for sleep is off-label and not backed by the same FDA-reviewed dosing and safety data as a dedicated insomnia drug. It is not a controlled substance, which can simplify prescribing, but it carries antidepressant-specific warnings that don't apply to Quviviq.
Pros
Generic and typically costs $20 to $70 a month without insurance
Not a controlled substance, so it's easier to refill
Long clinical history across millions of patients since 1981
May help patients who have both depression and insomnia
Cons
Off-label for insomnia; the FDA has not reviewed it for that use
Carries a boxed warning for suicidal thoughts in young patients
Can cause next-day grogginess due to its longer half-life
Risk of priapism and orthostatic hypotension, especially in older adults
Quviviq
Quviviq carries an FDA-approved insomnia indication, its own dosing table, and clinical trial data specifically on sleep onset and maintenance, which trazodone's label does not have. It's a Schedule IV controlled substance, so prescribing and refills involve more regulatory oversight, and its list price is far higher than generic trazodone.
Pros
FDA-approved and studied specifically for insomnia
No evidence of physical dependence or withdrawal in trials
No dose adjustment needed for kidney problems
Newer mechanism (dual orexin blocker) targets sleep-wake signaling directly
Cons
Roughly $520 to $685 a month without insurance, before savings programs
Schedule IV controlled substance, with added prescribing restrictions
Not recommended for patients with severe liver impairment
Less real-world, long-term use history than older generic options
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.